Showing results (331-340 of 435) with videos related to

Sort By:
Pageof 44
Journal of the American Society for Mass Spectrometry|October 2, 2025
Proteoform Characterization of HIV-1 Broadly Neutralizing Antibody PGT 121.414.LS Product Through Middle-Up and Bottom-Up Proteomics for Clinical SupportConnor E Gould, Qing Ma, Raymond Cha, et al.
Aquatic Toxicology (Amsterdam, Netherlands)|September 17, 2013
Molybdate:sulfate ratio affects redox metabolism and viability of the dinoflagellate Lingulodinium polyedrumM P Barros, H C Hollnagel, A B Glavina, et al.
The Journal of Antimicrobial Chemotherapy|April 15, 2014
Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypesDavid W Haas, Awewura Kwara, Danielle M Richardson, et al.
The Journal of Chemical Physics|November 18, 2025
Thermochemical properties of small rhenium molecules: ReC, ReN, ReO, ReS, and ReC2Kimberly H Tomchak, Erick Tieu, Thomas T Kawagoe, et al.
Pharmacotherapy|July 3, 1999
Comparison of a neural network approach with five traditional methods for predicting creatinine clearance in patients with human immunodeficiency virus infectionR A Herman, S Noormohamed, S Hirankarn, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 26, 2006
Pharmacokinetic drug interactions with non-nucleoside reverse transcriptase inhibitorsQing Ma, Olanrewaju O Okusanya, Patrick F Smith, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1996
Didanosine reduces atevirdine absorption in subjects with human immunodeficiency virus infectionsG D Morse, M A Fischl, M J Shelton, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2005
Amprenavir and efavirenz pharmacokinetics before and after the addition of nelfinavir, indinavir, ritonavir, or saquinavir in seronegative individualsGene D Morse, Susan Rosenkranz, Michael F Para, et al.
Reviews of Infectious Diseases|July 1, 1990
2',3'-Dideoxyinosine in patients with AIDS or AIDS-related complexR Dolin, J S Lambert, G D Morse, et al.
HIV Clinical Trials|January 25, 2008
The design and implementation of A5146, a prospective trial assessing the utility of therapeutic drug monitoring using an inhibitory quotient in antiretroviral-experienced HIV-infected patientsLisa M Demeter, A Lisa Mukherjee, Robin DiFrancesco, et al.
Pageof 44